Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
05/2003
05/21/2003EP0797442B1 Treatment of optic neuritis
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1418704A SOD nutriment capsule with high micro content
05/21/2003CN1418616A Cosmtics treatment using novel retinoid
05/20/2003US6566543 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury
05/20/2003US6566401 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine
05/20/2003US6566338 Administering caspase inhibitor for therapy of oral mucositis, gastrointestinal mucositis, bladder mucositis or proctitis resulting from chemotherapy or radiation therapy of cancer in an animal
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid
05/20/2003US6565885 Methods of spray drying pharmaceutical compositions
05/20/2003US6565854 Killing microorganisms, especially human pathogens; use in would dressings; animal feeds; vaccines
05/15/2003WO2003039569A1 Process for the preparation of anthocyanin-containaing products
05/15/2003WO2003039541A1 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body
05/15/2003WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003WO2003039418A1 Compositions for the treatment of infectious diseases
05/15/2003WO2002058730A3 Compositions for treatment of ocular neovascularization
05/15/2003WO2002038181A3 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092675 Skin treatment using a new retinoid
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030091659 Plant extracts; active materials
05/15/2003US20030091607 Wrinkle resistance; cosmetics
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003CA2466083A1 Compositions for the treatment of infectious diseases
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310262A1 Topical composition having undifferentiated plant seed cells and method for using same
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1309309A1 Dermatological composition
05/14/2003EP1309251A1 Selenium diet supplement
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1418087A Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light
05/14/2003CN1416893A Medicine containing recombinant human metallothionein and its prepn
05/14/2003CN1416841A Anti-anoxia health food composition
05/14/2003CN1416838A Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process
05/14/2003CN1416806A Local composition with undifferentiated plant seed cell and ifs usage
05/14/2003CN1416728A Health food capable of increasing bone density and delaying senility and its production process
05/13/2003US6562789 Histidine derivatives, preparation process, and their use as free antiradical agents
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6561976 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037379A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037339A1 Interferon $g(g) production promoter
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003020254A8 Pharmaceutical composition comprising (-)-secoisolariciresinol
05/08/2003WO2003000633A3 A process for the isolation of a major harmful oxidant from cigarette smoke
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030087965 Including neuropathic pain.
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2465369A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003CA2464945A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1019023B1 Stabilized preparations for use in nebulizers
05/07/2003CN1107520C Oral liquid of gingko
05/06/2003US6559135 Per-(3-6-anhydro)cyclodextrins derivatives, preparation and use thereof for separating ions
05/06/2003US6558925 Stem cell inhibitor
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/02/2003EP1306367A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305013A1 Preparation with vascular protective and anti-oxidative effect and use thereof
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1056475B1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035079A1 A combination product comprising melagatran and dexamethasone
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035005A2 Heteroindanes: a new class of potent cannabimimetic ligands
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002045525A3 Aged companion pet diet
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083382 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
04/2003
04/30/2003CN1414967A Silicon compounds derived from ascorbic acid, preparation method, composition containing the compounds and application
04/30/2003CN1413622A Product for reducing tumor marker and its production method
04/29/2003US6555545 Adenosine, caffeine, and 8-styryl-1,3,7-alkyl xanthine derivatives as wound healing agents
04/24/2003WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
04/24/2003WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
04/24/2003WO2003033017A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
04/24/2003WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases
04/24/2003WO2003033005A1 Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
04/24/2003WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 191